泛素特异性蛋白酶11通过去泛素化表皮生长因子受体促进肾脏纤维化中的部分上皮-间质转化
在慢性肾脏病患者肾脏中USP11高表达且与纤维化病变正相关、与肾功能负相关。条件性敲除USP11或用米托蒽醌药物抑制可减轻高尿酸血症肾病和叶酸诱导的小鼠肾纤维化模型病变并改善肾功能。机制上USP11去泛素化并保护EGFR免于蛋白酶体降解,从而促进TGF-β1信号、部分上皮-间质转化、G2/M阻滞及促纤维化促炎分泌组。
要点
- USP11在慢性肾脏病患者肾脏中高表达,与纤维化病变正相关、与肾功能负相关。
- 条件性敲除USP11或米托蒽醌抑制可减轻高尿酸血症肾病和叶酸诱导小鼠模型的肾脏病变并改善肾功能。
- USP11通过去泛素化保护EGFR免于蛋白酶体降解,促进TGF-β1信号及部分上皮-间质转化。
核心结论
- 研究提供证据支持USP11作为减轻肾脏纤维化的有前景靶点,抑制USP11有潜力成为慢性肾脏病患者的有效策略。
研究设计与样本
- 研究检测慢性肾脏病患者肾脏中USP11表达,并在高尿酸血症肾病和叶酸诱导的小鼠肾纤维化模型中采用条件性USP11敲除或米托蒽醌药物抑制进行干预。
主要发现
- USP11在慢性肾脏病患者肾脏中高度上调,与纤维化病变正相关、与肾功能负相关。
- 条件性敲除USP11或米托蒽醌药物抑制在高尿酸血症肾病和叶酸诱导的小鼠肾纤维化模型中均减轻病理病变并改善肾功能。
- RNA测序发现USP11参与EGFR的核基因转录。
- USP11与核外EGFR共免疫沉淀和共染色,去泛素化并保护EGFR免于蛋白酶体依赖性降解。
- 遗传或药物清除USP11促进EGFR降解并减弱TGF-β1及其下游信号的增强。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aberrant expression of ubiquitin-specific protease 11 (USP11) is believed to be related to tumor progression. However, few studies have reported the biological function and clinical importance of USP11 in kidney fibrosis. Here, we demonstrated USP11 was highly upregulated in the kidneys from patients with chronic kidney disease and correlated positively with fibrotic lesion but negatively with kidney function. Conditional USP11 deletion or pharmacologic inhibition with Mitoxantrone attenuated pathological lesions and improved kidney function in both hyperuricemic nephropathy (HN)- and folic acid (FA)-induced mouse models of kidney fibrosis. Mechanistically, by RNA sequencing, USP11 was found to be involved in nuclear gene transcription of the epidermal growth factor receptor (EGFR). USP11 co-immunoprecipitated and co-stained with extra-nuclear EGFR and deubiquitinated and protected EGFR from proteasome-dependent degradation. Genetic or pharmacological depletion of USP11 facilitated EGFR degradation and abated augmentation of TGF-β1 and downstream signaling. This consequently alleviated the partial epithelial-mesenchymal transition, G2/M arrest and aberrant secretome of profibrogenic and proinflammatory factors in uric acid-stimulated tubular epithelial cells. Moreover, USP11 deletion had anti-fibrotic and anti-inflammatory kidney effects in the murine HN and FA models. Thus, our study provides evidence supporting USP11 as a promising target for minimizing kidney fibrosis and that inhibition of USP11 has potential to be an effective strategy for patients with chronic kidney disease.
引用
- Shi Y, Tao M, Chen H, et al. Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney Int. 2022. PMID: 36581018. doi:10.1016/j.kint.2022.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。